{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

MSIF CEO attends MSLiving Convention 2007 in Ireland

Peer Baneke, MSIF CEO, was delighted to attend MS Ireland's MSLiving National Convention 2007 in Dublin on May 5.

read more

Quality of Life Principles Practice Database now ready for use

MSIF is delighted to announce that the QoL Principles Practice Database is now finished and ready to be used by member societies.

read more

Featured News

Report from Helen Tremlett, recipient of an MSIF Du Pré Grant during 2006

In November 2006, an MSIF Du Pré Grant enabled Helen Tremlett from the Neurology Division of the Faculty of Medicine, University of British Columbia in Canada to travel to the Menzies Research Institute, University of Tasmania in Australia.

read more

back to top

Profile of the Month : January 2008

Amal AbdulRahman

Age: 32
Country: Saudi Arabia
Occupation: Freelance teacher and translator
Year of diagnosis: 2001

"You are, through your soul not your body, a human being."

English Italiano Espanol Deutsch Francais Russian Arabic (May 2007 only)

read more

back to top

Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis

The authors used two recently developed MRI techniques in people with MS to conclude that metabolic dysfunction contributes to neuron damage independent of structural damage.

authors: Cader S, Johansen-Berg H, Wylezinska M, Palace J, Behrens TE, Smith S, Matthews PM.

source: Neuroimage. 2007 May 15;36(1):19-27

read more

Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas

The authors studied the mechanisms underlying the recovery from optic neuritis, one of the most common symptoms in MS. They found evidence of early brain reorganisation.

authors: Korsholm K, Madsen KH, Frederiksen JL, Skimminge A, Lund TE.

source: Brain. 2007 May;130(Pt 5):1244-53

read more

fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection

The authors, using a recently introduced MRI technique, looked at the fatigue occurring in people with MS after injections of interferon-beta. They found it to be caused by dysfunction of specific brain areas.

authors: Rocca MA, Agosta F, Colombo B, Mezzapesa DM, Falini A, Comi G, Filippi M.

source: Hum Brain Mapp. 2007 May;28(5):373-82.

read more

Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis

The authors looked at the mechanism of action of interferon-beta in preventing relapses in MS. They found that it could be related to a reduction in the number of immunological cells acting against the nerves.

authors: Zafranskaya M, Oschmann P, Engel R, Weishaupt A, van Noort JM, Jomaa H, Eberl M.

source: Immunology. 2007 May;121(1):29-39. Epub 2006 Dec 18.

read more

back to top

2007 John Dystel Prize for MS Research

source: US National MS Society

Professor Howard L. Weiner, MD, of Harvard Medical School, Boston, has been chosen by a committee of his peers to receive the US National MS Society/American Academy of Neurology's 2007 John Dystel Prize for Multiple Sclerosis Research.

read more

Spanish Red Cross Gold Medal awarded

source: FELEM

Today, FEM (Fundación Esclerosis Múltiple) Cataluña, a member of the Spanish MS Society FELEM (Federación Española para la Lucha contra la Esclerosis Múltiple), will receive the Gold Medal from the Spanish Red Cross in recognition of its work for people with MS.

read more

Canadian news website reports on rituximab

source: Medical News Today

A new drug under investigation for MS appears to be safe and effective according to studies involving researchers at the Montreal Neurological Institute.

read more

MS seminar in Riyadh, Saudi Arabia

source: www.ms-saudi.com

A seminar will be held at the Minhal Holiday Inn Riyadh on May 10 starting at 4pm (dinner included) and is open to all but the target audience is people with MS and their families.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.